Aromatic L-amino acid decarboxylase deficiency: overview of clinical features and outcomes

Kathryn J Swoboda1, J Philip Saul, Catherine E McKenna

  • 1Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT 84132, USA. swoboda@genetics.utah.edu

Annals of Neurology
|August 2, 2003
PubMed

Insights

L-amino acid decarboxylase deficiency presents with early-onset movement disorders and autonomic dysfunction. Clinical outcomes remain poor, highlighting the need for improved L-amino acid decarboxylase deficiency treatments.

Area of Science:

  • Biochemistry
  • Neurology
  • Genetics

Background:

  • L-amino acid decarboxylase deficiency is a rare neurometabolic disorder.
  • Early diagnosis and understanding of its biochemical phenotype are crucial.

Purpose of the Study:

  • To update diagnostic considerations and biochemical phenotype of L-amino acid decarboxylase deficiency.
  • To review clinical features and outcomes in 11 affected patients.

Main Methods:

  • Case review of 11 patients with L-amino acid decarboxylase deficiency, including 7 new cases.
  • Analysis of clinical features, movement disorder phenomenology, and autonomic dysfunction.
  • Assessment of functional clinical outcomes and treatment interventions.

Main Results:

  • All patients exhibited onset of movement disorder by 6 months of age.
  • Characteristic movement disorder includes oculogyric crises, dystonia, athetosis, and impaired voluntary movement.
  • Significant autonomic dysfunction, particularly impaired sympathetic regulation, was observed.

Conclusions:

  • Functional clinical outcomes for L-amino acid decarboxylase deficiency remain poor, with significant motor and communication impairments.
  • Outcome variability exists among patients despite various treatment attempts.
  • Further research is needed to identify optimal treatment strategies for L-amino acid decarboxylase deficiency.

Related Concept Videos

Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives01:35

Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives

Just like β-keto acids—which upon thermal decarboxylation form ketones—β-dicarboxylic acids undergo decarboxylation to generate monocarboxylic acids with the liberation of carbon dioxide.
Aromatic Compounds: Overview01:25

Aromatic Compounds: Overview

In general, the term ‘aromatic’ indicates a pleasant smell or fragrance from fresh flowers, freshly prepared coffee, etc. In the early history of organic chemistry, many benzene derivatives were isolated from the pleasant odor oils of the plants. For example, vanillin was isolated from the oil of vanilla, methyl salicylate from the oil of wintergreen, and cinnamaldehyde from the oil of cinnamon. They all had a pleasant odor; hence the name aromatic was given.
In 1825, Faraday isolated benzene...
Loss of Carboxy Group as CO2: Decarboxylation of β-Ketoacids01:02

Loss of Carboxy Group as CO2: Decarboxylation of β-Ketoacids

Carboxylic acids, upon heating, undergo a decarboxylation reaction by releasing carbon dioxide gas. Monocarboxylic acids do not undergo decarboxylation easily. However, a silver salt of carboxylic acid reacts with bromine or iodine under high temperature to release carbon dioxide gas and forms halide with one less carbon. This reaction is called the Hunsdiecker reaction.
Amino Acid Biosynthetic Pathways01:29

Amino Acid Biosynthetic Pathways

Amino acid biosynthesis is essential for cell growth, protein synthesis, and metabolic regulation. Cells generate essential and non-essential amino acids from metabolic intermediates to sustain vital biological functions. These intermediates originate from key metabolic pathways: glycolysis, the tricarboxylic acid (TCA) cycle, and the pentose phosphate pathway. Important precursors include α-ketoglutarate, pyruvate, oxaloacetate, phosphoenolpyruvate, and erythrose-4-phosphate, which provide...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...